Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Intrinsic Value
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. [ Read More ]
The intrinsic value of one Hansoh Pharmaceutical Group Company Ltd stock under the Base Case scenario is 15.09 HKD. Compared to the current market price of 18 HKD, Hansoh Pharmaceutical Group Company Ltd is Overvalued by 16%.
Valuation Backtest
Hansoh Pharmaceutical Group Company Ltd
Run backtest to discover the historical profit from buying and selling Hansoh Pharmaceutical Group Company Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Hansoh Pharmaceutical Group Company Ltd
| Current Assets | 28.9B |
| Cash & Short-Term Investments | 24.9B |
| Receivables | 3.2B |
| Other Current Assets | 812m |
| Non-Current Assets | 4.2B |
| Long-Term Investments | 684.7m |
| PP&E | 3.3B |
| Intangibles | 177.4m |
| Current Liabilities | 6.9B |
| Accounts Payable | 163.8m |
| Other Current Liabilities | 6.7B |
| Non-Current Liabilities | 381.5m |
| Long-Term Debt | 104.5m |
| Other Non-Current Liabilities | 277m |
Earnings Waterfall
Hansoh Pharmaceutical Group Company Ltd
|
Revenue
|
10.1B
CNY
|
|
Cost of Revenue
|
-1B
CNY
|
|
Gross Profit
|
9.1B
CNY
|
|
Operating Expenses
|
-5.4B
CNY
|
|
Operating Income
|
3.7B
CNY
|
|
Other Expenses
|
-393.8m
CNY
|
|
Net Income
|
3.3B
CNY
|
Free Cash Flow Analysis
Hansoh Pharmaceutical Group Company Ltd
Profitability Score
Profitability Due Diligence
Hansoh Pharmaceutical Group Company Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
Score
Hansoh Pharmaceutical Group Company Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Hansoh Pharmaceutical Group Company Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Hansoh Pharmaceutical Group Company Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Hansoh Pharmaceutical Group Company Ltd
According to Wall Street analysts, the average 1-year price target for Hansoh Pharmaceutical Group Company Ltd is 18.77 HKD with a low forecast of 12.02 HKD and a high forecast of 29.4 HKD.
Shareholder Return
Price
Hansoh Pharmaceutical Group Company Ltd
| Average Annual Return | 2.2% |
| Standard Deviation of Annual Returns | 44.57% |
| Max Drawdown | -79% |
| Market Capitalization | 106.8B HKD |
| Shares Outstanding | 5 918 991 200 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Lianyungang, Jiangsu. The company went IPO on 2019-06-14. The Company’s main products include Oulanning, Ameining, Pulaile, Zefei, Xinwei, Xinmei, Zetan, Mailingda, Hengjie, Hengsen, Fulaidi and Ruibote, among others. The Company’s products are mainly used for central nervous system disease, oncology, anti-infection, diabetes, digestive tract and cardiovascular treatment. The firm distributes its products in domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one Hansoh Pharmaceutical Group Company Ltd stock under the Base Case scenario is 15.09 HKD.
Compared to the current market price of 18 HKD, Hansoh Pharmaceutical Group Company Ltd is Overvalued by 16%.
You don't have any saved screeners yet
